Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions

CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large cell lymphoma and Hodgkin lymphoma, among others. The variable expression of CD30 on both normal and malignant lymphoid cells has f...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Weyden, C A, Pileri, S A, Feldman, A L, Whisstock, J, Prince, H M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709754/
https://www.ncbi.nlm.nih.gov/pubmed/28885612
http://dx.doi.org/10.1038/bcj.2017.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709754/
https://www.ncbi.nlm.nih.gov/pubmed/28885612
http://dx.doi.org/10.1038/bcj.2017.85

Ejemplares similares